259 related articles for article (PubMed ID: 21224835)
41. AAV Gene Augmentation Therapy for CRB1-Associated Retinitis Pigmentosa.
Alves CH; Wijnholds J
Methods Mol Biol; 2018; 1715():135-151. PubMed ID: 29188511
[TBL] [Abstract][Full Text] [Related]
42. Ocular findings associated with rhodopsin gene codon 17 and codon 182 transition mutations in dominant retinitis pigmentosa.
Fishman GA; Stone EM; Sheffield VC; Gilbert LD; Kimura AE
Arch Ophthalmol; 1992 Jan; 110(1):54-62. PubMed ID: 1731723
[TBL] [Abstract][Full Text] [Related]
43. Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
O'Neill B; Millington-Ward S; O'Reilly M; Tuohy G; Kiang AS; Kenna PF; Humphries P; Farrar GJ
Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2863-9. PubMed ID: 10967039
[TBL] [Abstract][Full Text] [Related]
44. Ocular findings associated with rhodopsin gene codon 267 and codon 190 mutations in dominant retinitis pigmentosa.
Fishman GA; Vandenburgh K; Stone EM; Gilbert LD; Alexander KR; Sheffield VC
Arch Ophthalmol; 1992 Nov; 110(11):1582-8. PubMed ID: 1444916
[TBL] [Abstract][Full Text] [Related]
45. Long-term retinal function and structure rescue using capsid mutant AAV8 vector in the rd10 mouse, a model of recessive retinitis pigmentosa.
Pang JJ; Dai X; Boye SE; Barone I; Boye SL; Mao S; Everhart D; Dinculescu A; Liu L; Umino Y; Lei B; Chang B; Barlow R; Strettoi E; Hauswirth WW
Mol Ther; 2011 Feb; 19(2):234-42. PubMed ID: 21139570
[TBL] [Abstract][Full Text] [Related]
46. Filtration of Short-Wavelength Light Provides Therapeutic Benefit in Retinitis Pigmentosa Caused by a Common Rhodopsin Mutation.
Orlans HO; Merrill J; Barnard AR; Charbel Issa P; Peirson SN; MacLaren RE
Invest Ophthalmol Vis Sci; 2019 Jun; 60(7):2733-2742. PubMed ID: 31247114
[TBL] [Abstract][Full Text] [Related]
47. Low incidence of retinitis pigmentosa among heterozygous carriers of a specific rhodopsin splice site mutation.
Rosenfeld PJ; Hahn LB; Sandberg MA; Dryja TP; Berson EL
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2186-92. PubMed ID: 7558711
[TBL] [Abstract][Full Text] [Related]
48. Silencing gene therapy for mutant membrane, secretory, and lipid proteins in retinitis pigmentosa (RP).
Shinohara T; Mulhern ML; Madson CJ
Med Hypotheses; 2008; 70(2):378-80. PubMed ID: 17590524
[TBL] [Abstract][Full Text] [Related]
49. Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy.
Tschernutter M; Schlichtenbrede FC; Howe S; Balaggan KS; Munro PM; Bainbridge JW; Thrasher AJ; Smith AJ; Ali RR
Gene Ther; 2005 Apr; 12(8):694-701. PubMed ID: 15660111
[TBL] [Abstract][Full Text] [Related]
50. Novel mutations in the NRL gene and associated clinical findings in patients with dominant retinitis pigmentosa.
DeAngelis MM; Grimsby JL; Sandberg MA; Berson EL; Dryja TP
Arch Ophthalmol; 2002 Mar; 120(3):369-75. PubMed ID: 11879142
[TBL] [Abstract][Full Text] [Related]
51. A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa.
Rosenfeld PJ; Cowley GS; McGee TL; Sandberg MA; Berson EL; Dryja TP
Nat Genet; 1992 Jun; 1(3):209-13. PubMed ID: 1303237
[TBL] [Abstract][Full Text] [Related]
52. Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).
Tam LC; Kiang AS; Kennan A; Kenna PF; Chadderton N; Ader M; Palfi A; Aherne A; Ayuso C; Campbell M; Reynolds A; McKee A; Humphries MM; Farrar GJ; Humphries P
Hum Mol Genet; 2008 Jul; 17(14):2084-100. PubMed ID: 18385099
[TBL] [Abstract][Full Text] [Related]
53. Gene therapy restores vision and delays degeneration in the CNGB1(-/-) mouse model of retinitis pigmentosa.
Koch S; Sothilingam V; Garcia Garrido M; Tanimoto N; Becirovic E; Koch F; Seide C; Beck SC; Seeliger MW; Biel M; Mühlfriedel R; Michalakis S
Hum Mol Genet; 2012 Oct; 21(20):4486-96. PubMed ID: 22802073
[TBL] [Abstract][Full Text] [Related]
54. Wheel running exercise protects against retinal degeneration in the I307N rhodopsin mouse model of inducible autosomal dominant retinitis pigmentosa.
Zhang X; Girardot PE; Sellers JT; Li Y; Wang J; Chrenek MA; Wu W; Skelton H; Nickerson JM; Pardue MT; Boatright JH
Mol Vis; 2019; 25():462-476. PubMed ID: 31523123
[TBL] [Abstract][Full Text] [Related]
55. Autosomal dominant retinitis pigmentosa with a rhodopsin mutation (Arg-135-Trp). Disease phenotype in a Swedish family.
Ponjavic V; Abrahamson M; Andréasson S; Ehinger B; Fex G
Acta Ophthalmol Scand; 1997 Apr; 75(2):218-23. PubMed ID: 9197578
[TBL] [Abstract][Full Text] [Related]
56. Ocular findings in a form of retinitis pigmentosa with a rhodopsin gene defect.
Berson EL
Trans Am Ophthalmol Soc; 1990; 88():355-88. PubMed ID: 2095030
[TBL] [Abstract][Full Text] [Related]
57. Long-term protection of retinal structure but not function using RAAV.CNTF in animal models of retinitis pigmentosa.
Liang FQ; Aleman TS; Dejneka NS; Dudus L; Fisher KJ; Maguire AM; Jacobson SG; Bennett J
Mol Ther; 2001 Nov; 4(5):461-72. PubMed ID: 11708883
[TBL] [Abstract][Full Text] [Related]
58. Long-term RNA interference gene therapy in a dominant retinitis pigmentosa mouse model.
Jiang L; Zhang H; Dizhoor AM; Boye SE; Hauswirth WW; Frederick JM; Baehr W
Proc Natl Acad Sci U S A; 2011 Nov; 108(45):18476-81. PubMed ID: 22042849
[TBL] [Abstract][Full Text] [Related]
59. RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture.
Palfi A; Ader M; Kiang AS; Millington-Ward S; Clark G; O'Reilly M; McMahon HP; Kenna PF; Humphries P; Farrar GJ
Hum Mutat; 2006 Mar; 27(3):260-8. PubMed ID: 16419083
[TBL] [Abstract][Full Text] [Related]
60. A point mutation of the rhodopsin gene in one form of retinitis pigmentosa.
Dryja TP; McGee TL; Reichel E; Hahn LB; Cowley GS; Yandell DW; Sandberg MA; Berson EL
Nature; 1990 Jan; 343(6256):364-6. PubMed ID: 2137202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
